Alzheimer’s disease may be leaving a more precise anatomical signature in the brain than scientists once realized. A new study published in Translational Psychiatry investigates regional changes in the fine structure of brain tissue immediately beneath the cerebral cortex, known as the juxtacortical region, and links those changes to patterns of gene expression associated with neurodegeneration. The work, led by J. Zhang, L. Sun, X. Yang and colleagues, offers a combined view of Alzheimer’s biology that connects what can be detected through brain imaging with the molecular programs active inside vulnerable neural tissue.

The juxtacortical zone is a narrow but biologically important interface. It lies directly beneath the cortex, the outer layer responsible for functions including memory, language, perception and decision-making. Although much Alzheimer’s research has focused on cortical thinning, large-scale tissue loss and abnormalities in deeper brain structures, the tissue bordering the cortex may reveal earlier or more regionally specific changes. Its organization includes densely packed axons, dendrites, neurons, glial cells and blood vessels, all of which can be affected as the disease progresses. Subtle disruption in this area could therefore provide clues before dramatic anatomical damage becomes visible.

The study’s central idea is that Alzheimer’s disease does not alter every brain region in the same way. Instead, neurodegeneration follows a complex geography shaped by cellular composition, connectivity, metabolism and genetic vulnerability. By examining regional juxtacortical microstructural changes, the researchers seek to move beyond a simple question of whether tissue has shrunk. Microstructure refers to the organization of brain components at scales smaller than conventional anatomical imaging can directly resolve. Variations in water diffusion, tissue organization and local architecture can serve as indirect markers of changes to axons, membranes, extracellular space and other microscopic features.

This regional perspective matters because the same imaging signal can arise from different biological processes. A change in tissue organization may reflect loss of neuronal connections, damage to myelinated fibers, altered glial activity, inflammation or shifts in the balance of cellular compartments. Imaging alone can reveal where abnormalities are concentrated, but it cannot always explain why they occur. The researchers therefore paired their investigation of juxtacortical structure with gene-expression information, creating a bridge between regional anatomy and molecular biology. That combination can help identify which biological pathways may underlie the imaging patterns seen in Alzheimer’s disease.

Gene expression describes the activity of genes within cells and tissues: which genetic instructions are being read, and at what levels. In the Alzheimer’s brain, these molecular signatures can point toward processes such as synaptic dysfunction, immune activation, impaired energy production, protein handling and cellular stress. Mapping gene-expression patterns onto regions showing microstructural alterations may reveal whether vulnerable areas share particular molecular characteristics. It may also help distinguish tissue changes related directly to neurodegeneration from those associated with aging or general brain atrophy. The result is a more layered portrait of disease, linking microscopic organization to the biological machinery that maintains it.

The findings described by the paper’s title suggest that these two forms of evidence—regional microstructure and gene activity—provide complementary insights into Alzheimer’s pathology. Rather than treating the brain as a uniform organ undergoing gradual damage, the research emphasizes a mosaic of vulnerability. Some areas may show distinctive structural disruption alongside gene-expression profiles associated with neuronal injury or altered support-cell function, while other regions may be relatively resilient. Such differences could help explain why symptoms vary between individuals and why memory, language, attention and other abilities can deteriorate along different trajectories.

The work could also influence how scientists think about biomarkers. A biomarker is a measurable biological feature that helps indicate disease presence, progression or response to treatment. Traditional markers of Alzheimer’s include abnormal amyloid and tau proteins, brain volume loss and changes in metabolism. Juxtacortical microstructural measures, especially when interpreted alongside molecular data, could eventually add regional detail to this toolkit. They might help researchers identify tissue at risk, track the spread of degeneration or evaluate whether an experimental therapy is protecting neural architecture even before clinical improvement becomes obvious.

However, the study should not be interpreted as proof that a single imaging signature can diagnose Alzheimer’s disease or predict an individual’s future with certainty. Microstructural measurements are indirect, and gene-expression data often come from specialized datasets that may not capture every cell type or every stage of disease. Differences in age, disease severity, medication, vascular health and individual brain organization can also influence results. The strength of the approach lies not in one isolated measurement, but in the convergence of regional imaging and molecular evidence. Together, these methods can generate testable hypotheses about how and where neurodegeneration unfolds.

The broader message is that Alzheimer’s research is moving toward increasingly integrated maps of the human brain. The study by Zhang, Sun, Yang and colleagues presents the juxtacortical region as a potentially informative frontier, where microscopic tissue organization and gene regulation intersect. If future research confirms these relationships in larger and more diverse groups, the approach could sharpen disease staging and improve the design of targeted therapies. For now, the findings add weight to a crucial principle in neuroscience: understanding Alzheimer’s requires knowing not only which brain regions are damaged, but also how their cellular architecture and molecular identity make them vulnerable.

Subject of Research: Regional juxtacortical microstructural changes and gene expression in Alzheimer’s disease

Article Title: Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer’s disease

Article References: Zhang, J., Sun, L., Yang, X. et al. “Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer’s disease.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04292-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04292-z

Keywords: Alzheimer’s disease, neurodegeneration, juxtacortical microstructure, gene expression, brain imaging, neuroscience, biomarkers, translational psychiatry

Scientists have uncovered the genetic secrets behind a novel energy-use strategy that allows a deep-sea “giant” to survive without food for over five years, in one of nature’s most stunning survival stories.

Supergiant bathynomids, also known as giant isopods, present a bizarre biological paradox: they exhibit pronounced body gigantism as megafaunal species yet inhabit a deep-sea habitat with extremely sparse nutrient availability.

In a recent paper in Cell, researchers from the Institute of Oceanology of the Chinese Academy of Sciences (IOCAS) revealed how these large deep-sea creatures subsist on such limited food, using a novel genetic strategy unique to bathynomids.

A Complex Genetic Approach

The IOCAS team employed a multi-omic strategy to address the problem, combining genomics with other disciplines, such as morphology, physiology, behaviorology, and metagenomics. Doing so led to a novel discovery: that supergiant bathynomids don’t have just one, but two techniques to manage their limited access to nutrients.

First, isopods have a massive stomach that can store vast amounts of nutrients for later use. Second, they have an exceptionally low basal metabolic rate (BMR), which is genetically driven.

To diversify their research, the team focused on two species that occupy different depths. At around 300 meters, the Bathynomus doederleini is the shallower of the two, while the Bathynomus jamesi is found at 898 meters. Despite the difference in depth, both are technically considered “deep-sea” inhabitants, as the boundary is defined at 200 meters.

A Powerful Stomach

Roughly two-thirds of a bathynomid’s body is stomach—a figure far beyond that of related intertidal and shallow water species. The contents of those enormous stomachs are also unusual, filled with a mud-like mixture of highly digested food. This finely ground nutrient sludge has a low proportion of digestive bacteria, but a high amount of lipid-storing Chlamydiae. 

With a bacterial ratio leaning toward preservation rather than just digestion, this creates a food reserve that can be slowly digested and utilized as the creatures lower their BMR to endure long periods between feedings.

Genetic Findings

Another major finding was that bathynomids benefit not only from vertically transferred genes between parents and offspring, but from the horizontally transferred ND1 gene they acquired from an exogenous symbiotic bacterium. Intriguingly, the transfer defied typical horizontal transfer limitations, achieving an ultra-high level of expression in the bathynomid genome. 

These isopods use epigenetic histone modifications to regulate energy-related gene expression, thereby improving efficiency, conservation, and control. An example of this is histone acetylation regulating ND1 expression at an ultra-high level, which the team investigated in a laboratory test. Researchers suspected this gene was essential to energy metabolism, as it is a component of Complex I in the electron transport chain.

ND1 Genetic Tests

Using zebrafish, nematodes, and human 293T cells, the IOCAS team tested the gene’s impact on energy usage. At normal temperatures, the team found that ND1 actually decreased starvation tolerance by increasing energy metabolism. Yet when the team lowered temperatures to reflect those found in a typical deep sea environment, they found the opposite effect, with ND1 decreasing mitochondrial activity and energy metabolism rates, to improve zebrafish starvation tolerance an astounding 37%.

The IOCAS team concluded that ND1 provides a solution to the long-standing paradox of bathynomid gigantism in the context of their nutrient-poor environment. By fine-tuning the degree of metabolic depression, the gene can adjust the mitochondrial metabolic network to preserve energy during extended periods without sustenance.

Never before has such a strategy for energy efficiency, combining horizontal gene transfer and epigenetic optimization, been identified in a deep-sea megafaunal species.

“Our work not only deciphers the mystery of ultra-long starvation tolerance in deep-sea isopods,” said lead author Yuan Jianbo, “but also provides an important paradigm for understanding how life balances growth and survival in extreme environments.”

The paper, “Deep-Sea Megafauna Co-Opts Microbial Energy Metabolism Genes to Withstand Ultra-Long Starvation,” appeared in Cell on June 5, 2026.

Ryan Whalen covers science and technology for The Debrief. He holds an MA in History and a Master of Library and Information Science with a certificate in Data Science. He can be contacted at ryan@thedebrief.org, and follow him on Twitter @mdntwvlf.